ESCITALOPRAM OXALATE
- Product NDC
- 61919-139
- 11-digit product format
- 619190139
- Labeler code
- 61919
- Product ID
- 61919-139_d929b068-4c88-0c5c-e053-2995a90ab99a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ESCITALOPRAM OXALATE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Direct Rx
- Application
- ANDA090939
- Marketing category
- ANDA
- Marketing start
- 2015-01-01
- Marketing end
- 0000-00-00
- Substance
- ESCITALOPRAM OXALATE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 61919-139-30 | ESCITALOPRAM OXALATE | 30 in 1 BOTTLE | TABLET | 30 | | 7 |
| 61919-139-60 | ESCITALOPRAM OXALATE | 60 in 1 BOTTLE | TABLET | 60 | | 7 |
| 61919-139-90 | ESCITALOPRAM OXALATE | 90 in 1 BOTTLE | TABLET | 90 | | 7 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 61919-139 | ESCITALOPRAM OXALATE TABLET [DIRECT RX] | 7 | Legacy NDC, 3 package rows | 20220303_ce8be2b4-1525-4864-99c1-9e24815957dc.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 61919-139-30 | 61919013930 | 30 TABLET in 1 BOTTLE (61919-139-30) | 30 tablet | 2015-01-01 | 0000-00-00 | No | No | Current |
| 61919-139-60 | 61919013960 | 60 TABLET in 1 BOTTLE (61919-139-60) | 60 tablet | 2015-01-01 | 0000-00-00 | No | No | Current |
| 61919-139-90 | 61919013990 | 90 TABLET in 1 BOTTLE (61919-139-90) | 90 tablet | 2015-01-01 | 0000-00-00 | No | No | Current |